Pain Management Therapeutics

Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids, Other Non-narcotic Analgesic, and Antimigraine Agents; Indication - Neuropathic Pain, Fibromyalgia, Arthritic Pain, Chronic Back Pain, Migraine, Post-Operative Pain, and Cancer Pain) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL1059
  • Published On : Nov 2017
  • No. of Pages : 166
  • Category : Pharmaceutical

Section 1 Preface
1.1 Report Scope
1.2 Market Segmentation 
1.3 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Acronyms Used
2.3 Research Methodology

Section 3 Executive Summary

Section 4 Market Overview
4.1 Product Overview
4.2 Key Industry Developments
4.3 Market Opportunity Map
4.4 Porter’s Analysis 
4.5 Global Pain Management Therapeutics Market Outlook

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Trends
5.6 Most Types of Body Pain Location Globally and Cut by Gender and Parents 
5.7 Pain Management Therapeutics Pipeline Analysis – Snapshot 
5.8 Opioids with FDA-Approved Labeling Describing Abuse-Deterrent Properties 
5.9 Global Pain Management Therapeutics Market Value (Revenue)
5.10 Pain Management Therapeutics Market Outlook

Section 6 Pain Management Therapeutics Market Analysis, by Therapeutics Type
6.1 Key Findings
6.2 Introduction
6.3 Global Pain Management Therapeutics Market Value Share Analysis, by Therapeutics Type
6.4 Global Pain Management Therapeutics Market Forecast, by Therapeutics Type
       6.4.1 Global Pain Management Therapeutics Market Value Share Analysis, by Opioids
       6.4.2 Global Pain Management Therapeutics Market Forecast, by Opioids 
       6.4.3 Global Anticonvulsants Therapeutics Market, US$ Mn, 2015–2025
       6.4.4 Global Antidepressants Therapeutics Market, US$ Mn, 2015–2025
       6.4.5 Global Anesthetics Therapeutics Market, US$ Mn, 2015–2025
       6.4.6 Global NSAIDs Therapeutics Market, US$ Mn, 2015–2025
       6.4.7 Global Opioids Therapeutics Market, US$ Mn, 2015–2025
       6.4.8 Global Ant migraine Agents Therapeutics Market, US$ Mn, 2015–2025
       6.4.9 Global Other Non-narcotic Analgesics Therapeutics Market, US$ Mn, 2015–2025
6.5 Global Pain Management Therapeutics Market Analysis, by Therapeutics
6.6 Global Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics

Section 7 Global Pain Management Therapeutics Market Analysis, by Indication
7.1 Key Findings
7.2 Introduction
7.3 Global Pain Management Therapeutics Market Value Share Analysis, By Indication, 2016 and 2025
7.4 Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, By Indication, 2015–2025
       7.4.1 Global Neuropathic Pain Market, US$ Mn, 2015–2025
       7.4.2 Global Fibromyalgia Market, US$ Mn, 2015–2025
       7.4.3 Global Arthritic Pain Market, US$ Mn, 2015–2025
       7.4.4 Global Chronic Back Pain Market, US$ Mn, 2015–2025
       7.4.5 Global Migraine Market, US$ Mn, 2015–2025
       7.4.6 Global Post-Operative Pain Market, US$ Mn, 2015–2025
       7.4.7 Global Cancer Pain Market, US$ Mn, 2015–2025
7.5 Global Pain Management Therapeutics Market Attractiveness By Indication

Section 8 Pain Management Therapeutics Market Analysis, by Region
8.1 Global Scenario, by Country
8.2 Global Pain Management Therapeutics Market Value Share Analysis By Region, 2016 and 2025
8.3 Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, By Region, 2015–2025
8.4 Global Pain Management Therapeutics Market Attractiveness Analysis, by Region

Section 9 North America Pain Management Therapeutics Market Analysis
9.1 Key Findings
9.2 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
9.3 North America Market Attractiveness Analysis, by Country
9.4 North America Market Value Share Analysis, by Country, 2017 and 2025
9.5 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015–2025
9.4 North America Market Value Share Analysis, by Therapeutics, 2017 and 2025
9.5 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics Type, 2015–2025
       9.5.1 North America Pain Management Therapeutics Market Value Share Analysis, by Opioids       
       9.5.2 North America Pain Management Therapeutics Market Forecast, by Opioids
9.6 North America Market Value Share Analysis, by Indication, 2017 and 2025
9.7 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
9.8 North America Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
9.9 North America Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 10 Europe Pain Management Therapeutics Market Analysis
10.1 Key Findings
10.2 Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
10.3 Europe Market Attractiveness Analysis, by Country
10.4 Europe Market Value Share Analysis, by Country, 2017 and 2025
10.5 Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015–2025
       10.5.1 Europe Pain Management Therapeutics Market Value Share Analysis, by Opioids
       10.5.2 Europe Pain Management Therapeutics Market Forecast, by Opioids
10.6 Europe Market Value Share Analysis, by Indication, 2017 and 2025
10.7 Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
10.8 Europe Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
10.9 Europe Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 11 Asia Pacific Pain Management Therapeutics Market Analysis
11.1 Key Findings
11.2 Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
11.3 Asia Pacific Market Attractiveness Analysis, by Country
11.4 Asia Pacific Market Value Share Analysis, by Country, 2017 and 2025
11.5 Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015–2025
       11.5.1 Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Opioids
       11.5.2 Asia Pacific Pain Management Therapeutics Market Forecast, by Opioids
11.6 Asia Pacific Market Value Share Analysis, by Indication, 2017 and 2025
11.7 Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
11.8 Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
11.9 Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 12 Rest of the World Pain Management Therapeutics Market Analysis
12.1 Key Findings
12.2 Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
12.3 Rest of the World Market Value Share Analysis, by Therapeutics, 2017 and 2025
12.4 Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics Type, 2015–2025
       12.4.1 Rest of the World Pain Management Therapeutics Market Value Share Analysis, by Opioids
       12.4.2 Rest of the World Pain Management Therapeutics Market Forecast, by Opioids
12.5 Rest of the World Market Value Share Analysis, by Indication, 2017 and 2025
12.6 Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
12.7 Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
12.8 Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 13 Competition Landscape
13.1 Competition Matrix
13.2 Heat Map Analysis
13.3 Company Profiles
       13.3.1 Pfizer Inc.
                 13.3.1.1 Company Details
                 13.3.1.2 Business Overview
                 13.3.1.3 Financial Overview
                 13.3.1.4 Strategic Overview
                 13.3.1.5 SWOT Analysis
       13.3.2 Depomed, Inc.
                 13.3.2.1 Company Details
                 13.3.2.2 Business Overview
                 13.3.2.3 Financial Overview
                 13.3.2.4 Strategic Overview
                 13.3.2.5 SWOT Analysis
       13.3.3 Endo International plc.
                 13.3.3.1 Company Details
                 13.3.3.2 Business Overview
                 13.3.3.3 Financial Overview
                 13.3.3.4 Strategic Overview
                 13.3.3.5 SWOT Analysis
       13.3.4 Purdue Pharma L.P.
                 13.3.4.1 Company Details
                 13.3.4.2 Business Overview
                 13.3.4.3 Financial Overview
                 13.3.4.4 Strategic Overview
                 13.3.4.5 SWOT Analysis
       13.3.5 Mallinckrodt Pharmaceuticals
                 13.3.5.1 Company Details
                 13.3.5.2 Business Overview
                 13.3.5.3 Financial Overview
                 13.3.5.4 Strategic Overview
                 13.3.5.5 SWOT Analysis
       13.3.6 Teva Pharmaceutical Industries Ltd.
                 13.3.6.1 Company Details
                 13.3.6.2 Business Overview
                 13.3.6.3 Financial Overview
                 13.3.6.4 Strategic Overview
                 13.3.6.5 SWOT Analysis
       13.3.7 Novartis AG
                 13.3.7.1 Company Details
                 13.3.7.2 Business Overview
                 13.3.7.3 Financial Overview
                 13.3.7.4 Strategic Overview
                 13.3.7.5 SWOT Analysis
       13.3.8 AstraZeneca plc.
                 13.3.8.1 Company Details
                 13.3.8.2 Business Overview
                 13.3.8.3 Financial Overview
                 13.3.8.4 Strategic Overview
                 13.3.8.5 SWOT Analysis
       13.3.9 Johnson & Johnson Services, Inc.
                 13.3.9.1 Company Details
                 13.3.9.2 Business Overview
                 13.3.9.3 Financial Overview
                 13.3.9.4 Strategic Overview
                 13.3.9.5 SWOT Analysis
       13.3.10 Merck & Co., Inc.
                 13.3.10.1 Company Details
                 13.3.10.2 Business Overview
                 13.3.10.3 Financial Overview
                 13.3.10.4 Strategic Overview
                 13.3.10.5 SWOT Analysis
       13.3.11 Abbott Laboratories
                 13.3.11.1 Company Details
                 13.3.11.2 Business Overview
                 13.3.11.3 Financial Overview
                 13.3.11.4 Strategic Overview
                 13.3.11.5 SWOT Analysis
       13.3.12 GlaxoSmithKline plc.
                 13.3.11.1 Company Details
                 13.3.11.2 Business Overview
                 13.3.11.3 Financial Overview
                 13.3.11.4 Strategic Overview
                 13.3.11.5 SWOT Analysis

List of Tables
 
Table 01: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 02: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Opioids, 2015–2025
Table 03: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 04: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country, 2015– 2025
Table 06: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 07: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Opioids, 2015– 2025
Table 08: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015– 2025
Table 09: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 10: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 11: Europe Pain Management Therapeutics Market Revenue (US$ Mn) Forecast, by Opioids, 2015–2025
Table 12: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 13: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 14: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015– 2025
Table 15: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Opioids, 2015–2025
Table 16: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 17: Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 18: Rest of the World Opioids Market Revenue, by Therapeutic, (US$ Mn), 2015–2025
Table 19: Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 20: List of Other Prominent Players
Table 21: List of Other Prominent Players
Table 22: List of Other Prominent Players 

List of Figures

Figure 01: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Market Value Share, by Region (2016)
Figure 03: Market Value Share, by Therapeutics (2016)
Figure 04: Market Value Share, by Opioids (2016)
Figure 05: Market Value Share, by Indication (2016)
Figure 06: Global Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 07: Global Pain Management Therapeutics Market Value Share Analysis, by Opioids, 2016 and 2025
Figure 08: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anticonvulsants, 2015–2025
Figure 09: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Antidepressants, 2015–2025
Figure 10: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anesthetics, 2015–2025
Figure 11: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NSAIDs, 2015–2025
Figure 12: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Opioids, 2015–2025
Figure 13: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ant migraine Agents, 2015–2025
Figure 14: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Other Non-narcotic Analgesics, 2015–2025
Figure 15: Global Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017–2025
Figure 16: Global Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
Figure 17: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Neuropathic Pain, 2015–2025
Figure 18: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Fibromyalgia , 2015–2025
Figure 19: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Arthritic Pain, 2015–2025
Figure 20: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Chronic Back Pain , 2015–2025
Figure 21: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Migraine, 2015–2025
Figure 22: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Post-Operative Pain, 2015– 2025
Figure 23: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Cancer Pain, 2015–2025
Figure 24: Global Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2015–2025
Figure 25: Global Pain Management Therapeutics Market Value Share Analysis, by Region, 2016 and 2025
Figure 26: Global Pain Management Therapeutics Market Attractiveness Analysis, by Region, 2015–2025 
Figure 27: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 28: North America Pain Management Therapeutics Market Attractiveness Analysis, by Country, 2017– 2025
Figure 29: North America Pain Management Therapeutics Market Value Share Analysis, by Country, 2016 and 2025
Figure 30: North America Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 31: North America Pain Management Therapeutics Market Value Share Analysis, by Opioids, 2016 and 2025
Figure 32: North America Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
Figure 33: North America Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017–2025
Figure 34: North America Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2017– 2025
Figure 35: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 36: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 37: Europe Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 38: Europe Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 39: Europe Pain Management Therapeutics Market Value Share Analysis, by Opioids, 2016 and 2025
Figure 40: Europe Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
Figure 41: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017–2025
Figure 42: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2017–2025
Figure 43: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 44: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 45: Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 46: Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 47: Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Opioids, 2016 and 2025
Figure 48: Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
Figure 49: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017– 2025
Figure 50: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2017– 2025
Figure 51: Rest of the World Pain Management Therapeutics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 52: Rest of the World Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 53: Rest of the World Opioids Market Value Share Analysis, by Therapeutics, 2016 and 2025
Figure 54: Rest of the World Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
Figure 55: Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017–2025
Figure 56: Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2017–2025
Figure 57: Heat Map Analysis By Company (2016)
Figure 58: Pfizer Inc. Breakdown of Net Sales (2016), by Region
Figure 59: Pfizer Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2016
Figure 60: Depomed Inc. Breakdown of Net Sales for Pain Segment, 2016
Figure 61: Depomed Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 62: Endo International plc. Breakdown of Net Sales for Pain Segment, 2016
Figure 63: Endo International plc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 64: Mallinckrodt Pharmaceuticals Breakdown of Net Sales, by Business Segment, 2016
Figure 65: Mallinckrodt Pharmaceuticals Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 66: Novartis AG Breakdown of Net Sales, by Business Segment, 2016
Figure 67: Novartis AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 68: Teva Pharmaceutical Breakdown of Net Sales, by Business Segment, 2016
Figure 69: Teva Pharmaceutical Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 70: AstraZeneca plc. Breakdown of Net Sales, by Geography 2016
Figure 71: AstraZeneca plc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 72: J&J Breakdown of Net Sales, by Geography, 2016
Figure 73: J&J Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2016
Figure 74: Merck & Co.,Inc. Breakdown of Net Sales, by Business Segment, 2016
Figure 75: Merck & Co.,Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 76: Abbott laboratories Breakdown of Net Sales for Pain segment, 2016
Figure 77: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 78: GlaxoSmithKline plc. Breakdown of Net Sales, by Segment, 2016
Figure 79: GlaxoSmithKline plc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016

.